BIODANE PHARMA A/S: Financial statements 2015
CVR: 28310102
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
BIODANE PHARMA A/S (CVR 28310102) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK 437,995 and a net result of DKK -253,036 compared with DKK -250,379 the year before. That is an increase of 57% compared with the year before. Equity in the 2015 report amounted to DKK 733,542. The solvency ratio was 87.4%.
- Gross Profit
- DKK 437,995
- Profit/Loss
- DKK -253,036
- Equity
- DKK 733,542
- Total Assets
- DKK 839,257
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | 438 t. | -253 t. | 734 t. | - |
| 2014 | - | 279 t. | -250 t. | 987 t. | - |
| 2013 | - | 106 t. | -977 t. | -263 t. | - |
| 2012 | - | 384 t. | 8 t. | 714 t. | - |
Official annual report
How creditworthy is BIODANE PHARMA A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
BIODANE PHARMA A/S has published its annual report for 2014. Gross profit came to DKK 278,919, and the net result was DKK -250,379.
About BIODANE PHARMA A/S
BIODANE PHARMA A/S is a Danish company of the type Aktieselskab based in Gesten, founded in 2004. The company is registered under the industry Fremstilling af andre fødevarer i.a.n.. The company was previously named BIODANE PHARMA ApS and BIOFIBER TØRRING ApS. The management consists of Gunner Kreutzer Jakobsen. The board consists of Peter Gæmelke (chair), Flemming Torben Heden Knudsen, Gunner Kreutzer Jakobsen and Rasmus Juhl Rasmussen. The company is owned by BIODAN A/S. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 2,534,166 and a net result of DKK 182,862 compared with DKK 1,651,356 the year before. Equity in the 2025 report amounted to DKK 2,505,002.